Publications

Found 3 results
Author Title Type [ Year(Asc)]
Filters: Author is Otava, Tomáš  [Clear All Filters]
2024
Kocek, H.; Chalupská, D.; Dejmek, M.; Dvořáková, A.; Zgarbová, M.; Šála, M.; Chalupský, K.; Krafčíková, P.; Otava, T.; Drexler, M.; et al. Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5′-carboxamides. RSC Medicinal Chemistry 2024, nestránkováno.
2023
Štefek, M.; Chalupská, D.; Chalupský, K.; Zgarbová, M.; Dvořáková, A.; Krafčíková, P.; Li, A. Shi Ming; Šála, M.; Dejmek, M.; Otava, T.; et al. Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors. ACS Omega 2023, 8 (30), 27410-27418.
Dejmek, M.; Brázdová, A.; Otava, T.; Polidarová, M. Pimková; Klíma, M.; Smola, M.; Vavřina, Z.; Buděšínský, M.; Dračínský, M.; Liboska, R.; et al. Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy. European Journal of Medicinal Chemistry 2023, 259 (November).
xs sm md lg